| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jul 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 1,121,604 | 179.46 k | 1,121,604 |
| 6 Jun 24 | BDTX Black Diamond Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.65 | 30,550 | 142.06 k | 30,550 |
| 5 Jun 24 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 16.41 | 7,639 | 125.36 k | 7,639 |
